---
title: "Sanders’ Medicare for All Gains Increasing Support Among Democrats in Congress"
id: "stat-news-6-sanders-medicare-for-all-plan-accrues-more-liberal-and-moderate-support-in"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-6-sanders-medicare-for-all-plan-accrues-more-liberal-and-moderate-support-in"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/19/health-news-sanders-medicare-for-all-plan-accrues-more-support-in-congress/?utm_campaign=rss"
published_at: "2026-11-19T12:59:54.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Sanders’ Medicare for All Gains Increasing Support Among Democrats in Congress
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-6-sanders-medicare-for-all-plan-accrues-more-liberal-and-moderate-support-in
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/19/health-news-sanders-medicare-for-all-plan-accrues-more-support-in-congress/?utm_campaign=rss)
- **Published At:** 2026-11-19T12:59:54.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Sen. Bernie Sanders advocates lowering Medicare eligibility from 65 to 55, with added dental, vision, hearing, and free Medicaid coverage for children through age 19. - Sanders predicts this legislation could pass Congress with bipartisan potential, even under President Trump. - Key Senate figures, including Sen. Ron Wyden and Rep. Hakeem Jeffries, express alignment with Sanders' proposals, indicating growing liberal and moderate consensus. - Sanders plans investigations into health secretary Robert F. Kennedy Jr., insurance practices, and pharmaceutical pricing. - The FDA faces leadership uncertainty following the White House withdrawing Heidi Overton’s nomination, with acting commissioner Kyle Diamantas declining a permanent role. - Epic Systems responds to antitrust concerns, pledging a more open health record ecosystem to facilitate AI and third-party integration. - The Make America Healthy Again PAC disclosed $10 million in funds but allocated minimal resources to key contested races. - The U.S. Preventive Services Task Force convenes after a hiatus to update clinical recommendations on cervical cancer, perinatal depression, and alcohol use, amid membership scrutiny.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/19/health-news-sanders-medicare-for-all-plan-accrues-more-support-in-congress/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/19/health-news-sanders-medicare-for-all-plan-accrues-more-support-in-congress/?utm_campaign=rss) [Clinical trials](https://www.statnews.com/topic/clinical-trials/) [aging](https://www.statnews.com/topic/aging/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT@JPM27](https://www.statnews.com/jpm-conference-stat-events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Madness 2027](https://www.statnews.com/feature/stat-madness/apply/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) China's Biotech Powerhouse 25 We ranked the 25 most valuable publicly traded Chinese drugmakers [ See the list ](https://www.statnews.com/china-biotech-index-powerhouse-25/) Newsletter[Morning Rounds](https://www.statnews.com/category/health/morning-rounds/) # Sanders’ ‘Medicare for All’ plan accrues more liberal and moderate support in Congress ## Epic responds to antitrust allegations, what MAHA did with election funding, and more health news * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/19/health-news-sanders-medicare-for-all-plan-accrues-more-support-in-congress/?utm_campaign=rss) ![Bernie Sanders](https://www.statnews.com/wp-content/uploads/2023/02/AP20058809154735-645x645.jpg) Steve Helber/AP ![](https://www.statnews.com/wp-content/uploads/2025/04/Rose-Broderick2-avatar-round-80x80.png) ![](https://www.statnews.com/wp-content/uploads/2022/11/john-wilkerson-avatar-round-80x80.png) By [O. Rose Broderick](https://www.statnews.com/staff/rose-broderick/) and [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) Nov. 19, 2026 ![](https://www.statnews.com/wp-content/uploads/2025/04/Rose-Broderick2-avatar-round-80x80.png) [O. Rose Broderick](https://www.statnews.com/staff/rose-broderick/) 1. [](https://x.com/rosebroderick_ "X") rose.broderick@statnews.com Rose covers disability and mental health, and she helps write STAT’s daily [Morning Rounds newsletter](https://www.statnews.com/category/health/morning-rounds/). Confidential tips can be sent to Rose on Signal at rosebroderick.11. [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts ![](https://www.statnews.com/wp-content/uploads/2022/11/john-wilkerson-avatar-round-80x80.png) [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) 1. [](https://x.com/john_wilkerson "X") john.wilkerson@statnews.com John writes about the politics of health care, and he is the author of the twice-weekly [D.C. Diagnosis newsletter](https://www.statnews.com/signup/dc/). You can reach John on Signal at John_Wilkerson.07. [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts _Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.[Sign up here](https://www.statnews.com/signup/morning-rounds/)._ Tons of news coming from the nation’s capitol as Democrats set their agenda for next year, but it’s worth highlighting what else happened yesterday. Advertisement Epic officials publicly addressed whether their business practices choke innovation, as detailed in a [_STAT investigation_](https://www.statnews.com/2026/10/28/epic-systems-ehr-dominance-health-tech-antitrust-scrutiny/). What did they say? Scroll down. ## As White House pulls Heidi Overton nomination, what’s next for the FDA? After the White House pulled its nomination of Heidi Overton for commissioner of the Food and Drug Administration on Tuesday evening, the future of the agency that oversees $4.1 trillion worth of food, tobacco, and medical products is extremely unsettled. The agency’s current acting commissioner, Kyle Diamantas, has reportedly said he’s uninterested in taking the role permanently, and even indicated he doesn’t want to stay at the FDA past the new year. Meanwhile, it is very unlikely that Congress has enough time to install another nominee before January, meaning that Senate Democrats will have final say over the next commissioner. Advertisement Who in the White House tanked Overton’s nomination? Who will replace her? Some people have suggested Sen. Roger Marshall of Kansas, or even a little-known guy named Marty Makary. (The former FDA head did not respond to request for comment.) Where does this leave the agency? STAT’s Margaret Manto [_breaks it down_](https://www.statnews.com/2026/11/18/fda-after-heidi-overton-burning-questions-agency-future/). ## Sanders’ “Medicare for All” plan Sen. Bernie Sanders (I-Vt.) is feeling optimistic about the first stage of his plan to vastly expand health coverage in the U.S. He predicted at a Wednesday press conference that Democrats will pass legislation lowering the Medicare eligibility age while President Trump is still in office, and that Trump might not veto it. Sanders would like Congress to lower the Medicare eligibility age from 65 to 55, expand coverage to include dental, vision, and hearing care, and guarantee free Medicaid coverage to children until age 19. And he pushed back on the assumption that Trump would veto such a bill. “I am not absolutely certain that Trump would not sign it,” he said. The health committee does not have jurisdiction over Medicare, but Sen. Ron Wyden (D-Ore.), who is expected to lead the committee that does, said [_he is on board with Sanders’ plan_](https://www.statnews.com/2026/11/10/dc-diagnosis-wyden-sanders-aligned-on-medicare-for-all/). Rep. Hakeem Jeffries (D-N.Y.) [_also supports_](https://www.statnews.com/2026/11/13/democrats-eye-medicare-for-more-vs-medicare-for-all/) the “Medicare for More” and “Medikids” proposals, an indication the party’s liberal and moderate wings are quickly moving toward common ground on a health care agenda. Sanders also offered insights into the health care investigations he might undertake, including of health secretary Robert F. Kennedy Jr. and the insurance and pharma industries. “Taking a hard look at the way the insurance industry runs, how they distort health care. Taking a hard look at the pharmaceutical industry as to why we pay by far the highest prices in the world for prescription drugs. Those are areas that need investigation,” he said. — _John Wilkerson_ ## Why Cassidy rejected Trump’s pick to lead NSF Less than two months before he leaves office, Bill Cassidy took a stand. The Republican senator from Louisiana rejected Jim O’Neill as the nominee to lead the National Science Foundation, cancelling the vote to confirm him over doubts about his willingness to stand up for scientific integrity. Advertisement The high-ranking health official had previously served at the Department of Health and Human Services and Centers for Disease Control and Prevention under health secretary Kennedy. But O’Neill “did not do enough to stand up for science and against irresponsible decisions and statements” from Kennedy in those roles, Cassidy said at a meeting of his committee. More from my STAT colleagues on [_Cassidy’s bold move_](https://www.statnews.com/2026/11/18/bill-cassidy-rejects-jim-oneill-lead-national-science-foundation/) as his time in the Senate runs out. ## Epic responds to antitrust allegations, promises more open ecosystem At a panel discussion at HLTH, a health technology conference in Las Vegas, Epic’s executives for the first time responded directly to [_a STAT investigation_](https://www.statnews.com/2026/10/28/epic-systems-ehr-dominance-health-tech-antitrust-scrutiny/) that found the company is undercutting competition by selectively withholding data access needed by rival application developers. Officials at Epic, the largest maker of electronic health records, defended against allegations of anticompetitive conduct and said they are seeking to build a more open ecosystem amid a deluge of requests for integration coming from third-party software vendors. They also said the company would make it easier for companies to use AI to read data stored in the company’s platforms. Lots more juicy details from this panel, moderated by Brittany Trang. [Read more](https://www.statnews.com/2026/11/18/epic-defends-competitive-practices-promises-ai-access-to-records/). ## $10 million In the wake of the midterm elections, leaders of the Make America Healthy Again movement have said that their candidates were up against opponents with massive funding advantages. But filings show that the movement’s political arm had more than $10 million to spend during this election cycle. Instead of directing those funds to promising candidates, it funneled millions to allies, associated organizations, and pundits. One notable example: The PAC spent less than $50,000 on a California House race it called “the most direct ideological confrontation between the movement and its institutional opposition anywhere on the 2026 ballot.” It spent more money this cycle at Mastro’s Steakhouse D.C., a white-tablecloth spot that offers $110 porterhouse steaks. [Another great story](https://www.statnews.com/2026/11/19/maha-pac-how-it-spent-money-insiders-candidates-nonprofit/) from our DC team. Advertisement ## Influential preventive services panel to meet for first time in over a year Later this morning, a little-known but influential panel that recommends which preventive services must be covered by insurance will meet for the first time in more than a year, writes STAT’s Chelsea Cirruzzo. The U.S. Preventive Services Task Force will review recommendations related to cervical cancer, perinatal depression, and unhealthy alcohol use in teens and adults, all of which have not been updated in at least five years, and have been awaiting finalization since last year, when Kennedy canceled the group’s meetings and overhauled its membership. [_Read more_](https://www.statnews.com/2026/11/18/uspstf-task-force-after-rfk-jr-shakeup-to-meet/) from Chelsea Cirruzzo about the meeting and some of the new members’ conflict of interests. ## What we’re reading * NIH to move last group of its research chimps to a sanctuary, [_STAT_](https://www.statnews.com/pharmalot/2026/11/18/nih-to-move-last-group-of-research-chimps-to-sanctuary/) * California insurer pushes subscription model for GLP-1 drugs, [_Bloomberg_](https://www.bloomberg.com/news/articles/2026-11-18/california-insurer-pushes-subscription-model-for-glp-1-drugs) * How a multimillion-dollar donation led Mount Sinai to a ‘high-risk’ hire, [_Politico_](https://www.politico.com/news/2026/11/18/mount-sinai-medical-school-arnhold-prabjhot-singh-01162585) * Pennsylvania’s growing costs to contain measles outbreak, [_Axios_](https://www.axios.com/local/philadelphia/2026/11/18/pennsylvania-measles-outbreak-johns-hopkins-university-cost-funding) [FDA](https://www.statnews.com/topic/fda/), [health care](https://www.statnews.com/topic/health-care/), [health tech](https://www.statnews.com/topic/health-tech/), [White House](https://www.statnews.com/topic/white-house/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/04/Rose-Broderick2-avatar-round-80x80.png) [O. Rose Broderick](https://www.statnews.com/staff/rose-broderick/) 1. [](https://x.com/rosebroderick_ "X") 2. [](https://bsky.app/profile/rosebroderick.bsky.social "Bluesky") 3. Disability in Health Care Reporting Fellow 1. [](https://x.com/rosebroderick_ "X") 2. [](https://bsky.app/profile/rosebroderick.bsky.social "Bluesky") 3. Rose covers disability and mental health, and she helps write STAT’s daily [Morning Rounds newsletter](https://www.statnews.com/category/health/morning-rounds/). Confidential tips can be sent to Rose on Signal at rosebroderick.11. 2. ![](https://www.statnews.com/wp-content/uploads/2022/11/john-wilkerson-avatar-round-80x80.png) [John Wilkerson](https://www.statnews.com/staff/john-wilkerson/) 1. [](https://x.com/john_wilkerson "X") 2. Washington Correspondent 1. [](https://x.com/john_wilkerson "X") 2. John writes about the politics of health care, and he is the author of the twice-weekly [D.C. Diagnosis newsletter](https://www.statnews.com/signup/dc/). You can reach John on Signal at John_Wilkerson.07. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2025/09/TheWorkup_Illustration_MollyFerguson_093025-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statins](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/) 2. ![](https://www.statnews.com/wp-content/uploads/2024/03/AdobeStock_421143532_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Merck, Isomorphic Labs partner to develop oncology drug candidates](https://www.statnews.com/2026/11/19/merck-isomorphic-labs-partner-to-develop-oncology-drug-candidates/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_1874804219-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Beyond statins, one drug lowered heart attack risk by 20%](https://www.statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/11/LabDish_Frame_rfkjr-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/i
## Related Clinical Research

- [USPSTF to meet after yearlong pause to review key preventive recommendations](https://medichelpline.com/clinical-feed/stat-news-0-stat-influential-preventive-services-panel-to-meet-for-first-time-in-more-than.md)
- [Biotech rebound favors Chinese firms while Sofinnova secures $800M](https://medichelpline.com/clinical-feed/stat-news-6-stat-biotech-s-rebound-isn-t-lifting-all-boats-equally.md)
- [Higher Ultra-Processed Food Intake Linked to Greater Risk of Multiple Chronic Diseases](https://medichelpline.com/clinical-feed/medical-news-today-0-every-extra-100-grams-of-ultra-processed-foods-tied-to-greater-disease-risk.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.